Yahoo

ICBC (SEHK:1398) Q3 Results Highlight Steady Growth And Lingering NIM Pressure

Industrial and Commercial Bank of China walked into this Q3 2026 report with its Hong Kong listed stock grinding higher in recent weeks, up about 5.1% over 90 days and closing today at HK$7.895. The headline result is solid banking grunt work. Net income excluding extra items came in at CNY 111,958m on total revenue of CNY 197,064m, while the non performing loan ratio held around 1.29% according to management commentary.

The share price reaction looks calm compared with the underlying story. Earnings and loan quality point to a steady, slow burn rather than any sudden rerating trigger. This leaves today's move more about sentiment than surprise.

Like the steady net income and contained non performing loan ratio at Industrial and Commercial Bank of China but want exposure to banks and financials with even stronger balance sheets and cash generation profiles? Consider using our screener of resilient, lower risk businesses, and compare ICBC against the list of solid balance sheet and fundamentals stocks (200 results) .

Q3 2026 Earnings Summary

  • Revenue (Q3 2026 vs Q3 2025):CNY 197,064m vs. CNY 179,753m (up about 9.6%).

  • Net Income (Excl. Extra Items, Q3 2026 vs Q3 2025):CNY 111,958m vs. CNY 101,805m (up about 10.0%).

  • Basic EPS (Q3 2026 vs Q3 2025):CNY 0.30 vs. CNY 0.27 (up about 11.1%).

  • Non Performing Loans, NPL ratio (Q3 2026 vs Q3 2025):CNY 411,818m vs. CNY 404,838m, with a group NPL ratio around 1.29%, which management described as slightly improved year on year.

ICBC says its margin pressure has mostly run its course. Ask Charlie what makes ICBC so confident NIM has bottomed .

SEHK:1398 Trailing 12-Month Revenue & Expenses Breakdown as at Nov 2026
SEHK:1398 Trailing 12-Month Revenue & Expenses Breakdown as at Nov 2026

ICBC: AI, Fees And Capital Buffers On Trial

The bullish story claims ICBC can turn technology, capital strength and fee businesses into tougher earnings power over time.

"Enterprise-wide AI risk control, now active across 323 business scenarios in Industrial and Commercial Bank of China, creates room for more granular pricing and capital allocation in retail and corporate lending."

Q3 results give this some backing. Net income and basic EPS both grew roughly in line with revenue. The NPL ratio stayed at 1.29% despite bond holdings and inclusive finance exposure expanding. Management also reports AI and large language models now in 700+ scenarios, which points to broader adoption than the original 323 use cases.

One Narrative disagrees with today's price. → See where this Narrative says Industrial and Commercial Bank of China should trade .

ICBC Margin Squeeze Fears Meet Mixed Evidence

Bearish watchers argue that Industrial and Commercial Bank of China risks having its earning power capped by thinning spreads and stubborn credit costs.

"Although Industrial and Commercial Bank of China is rolling out an AI platform across more than 600 scenarios and using intelligent risk control to manage NPL disposals, the expected slow structural decline in net interest margin toward around 1.26% with additional pressure from bond yields and interbank liability costs could leave future net interest income and earnings growth below what current efficiency gains might imply."

Q3 tells a more nuanced story. NIM sits at 1.29% and is described as largely stable, with management guiding only modest narrowing into 2027. Earnings and revenue both rose and the NPL ratio held at 1.29%. That combination does not yet show margin compression or credit strain biting as hard as this bear scenario assumes, although the capital raise and faster bond growth keep the pressure test alive rather than resolved.

Hunt Quiet Mispricings Before They Close

Industrial and Commercial Bank of China just showed how a steady quarter can leave the share price largely unmoved. The real opportunity is finding stocks that could be undervalued before the market corrects them.

  • Company 1 - 48% below our estimate - uses rising client assets in longer-term products to shift from transaction-driven flows toward steadier fee and spread income.

  • Company 2 - 27% below our estimate - captures fresh orders as chipmakers restart capacity projects and medical customers scale biophotonics tools into regular production lines.

  • Company 3 - 37% below our estimate - folds a major bedding acquisition into a dealer network and online channel that are pulling shoppers from informal mattress sellers into branded formats.

Three companies from the same screener. Open all 194 potentially undervalued companies →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include 1398.HK .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: